Capricor Therapeutics, Inc.
CAPR
$26.01
-$0.15-0.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -108.11% | -159.58% | -140.35% | -150.39% | -126.48% |
| Total Depreciation and Amortization | 34.62% | 32.55% | 29.85% | 28.00% | 28.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 72.43% | 115.08% | 75.20% | 55.34% | 47.47% |
| Change in Net Operating Assets | 62.36% | 213.12% | 121.83% | 108.72% | 75.30% |
| Cash from Operations | -105.12% | -74.55% | -65.90% | -56.12% | -45.33% |
| Capital Expenditure | -958.66% | -661.86% | -378.29% | -60.65% | 10.79% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.06% | 195.25% | -2,249.28% | -968.67% | -7,602.89% |
| Cash from Investing | 2.10% | 183.90% | -5,267.84% | -1,276.13% | -6,903.74% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 66.29% | 62.92% | -14.43% | 435.17% | 440.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 66.29% | 62.92% | -14.43% | 435.17% | 440.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 239.36% | 8,215.27% | -182.28% | 1,374.72% | 614.24% |